427 related articles for article (PubMed ID: 18991629)
21. Design, structure-activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin-based sulfamates as steroid sulfatase inhibitors.
Chiu PF; Lin IC; Lu YL; Chang CN; Chan HY; Lin TS; Tsai KC; Hsieh YSY; Chen MJ; Lin MH; Liang PH
Bioorg Chem; 2023 Sep; 138():106581. PubMed ID: 37172437
[TBL] [Abstract][Full Text] [Related]
22. A Review on Anti-urease Potential of Coumarins.
Asghar H; Asghar H; Asghar T
Curr Drug Targets; 2021; 22(17):1926-1943. PubMed ID: 33618646
[TBL] [Abstract][Full Text] [Related]
23. Progress in the Chemistry of Naturally Occurring Coumarins.
Sarker SD; Nahar L
Prog Chem Org Nat Prod; 2017; 106():241-304. PubMed ID: 28762091
[TBL] [Abstract][Full Text] [Related]
24. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
Howell A; Howell SJ; Clarke R; Anderson E
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229
[TBL] [Abstract][Full Text] [Related]
25. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Dandriyal J; Singla R; Kumar M; Jaitak V
Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.
Kulkarni MV; Kulkarni GM; Lin CH; Sun CM
Curr Med Chem; 2006; 13(23):2795-818. PubMed ID: 17073630
[TBL] [Abstract][Full Text] [Related]
27. Coumarin: a promising scaffold for anticancer agents.
Kaur M; Kohli S; Sandhu S; Bansal Y; Bansal G
Anticancer Agents Med Chem; 2015; 15(8):1032-48. PubMed ID: 25553437
[TBL] [Abstract][Full Text] [Related]
28. Recent Literature Review on Coumarin Hybrids as Potential Anticancer Agents.
Shaik BB; Katari NK; Seboletswe P; Gundla R; Kushwaha ND; Kumar V; Singh P; Karpoormath R; Bala MD
Anticancer Agents Med Chem; 2023; 23(2):142-163. PubMed ID: 35440315
[TBL] [Abstract][Full Text] [Related]
29. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
[TBL] [Abstract][Full Text] [Related]
30. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
Woo LW; Purohit A; Reed MJ; Potter BV
J Med Chem; 1996 Mar; 39(7):1349-51. PubMed ID: 8691463
[No Abstract] [Full Text] [Related]
31. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives.
Kasperkiewicz K; Ponczek MB; Owczarek J; Guga P; Budzisz E
Molecules; 2020 Mar; 25(6):. PubMed ID: 32213944
[TBL] [Abstract][Full Text] [Related]
32. [Steroid sulfatase inhibitor].
Nakata T; Ishida H; Shiotsu Y
Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
[TBL] [Abstract][Full Text] [Related]
33. Anticancer Potential of Coumarin and its Derivatives.
Bhattarai N; Kumbhar AA; Pokharel YR; Yadav PN
Mini Rev Med Chem; 2021; 21(19):2996-3029. PubMed ID: 33820507
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of mitochondria-targeted coumarin-3-carboxamide fluorescent derivatives: Inhibiting mitochondrial TrxR2 and cell proliferation on breast cancer cells.
Li Y; Tang Q; Xie Y; He D; Yang K; Zheng L
Bioorg Med Chem Lett; 2021 Feb; 33():127750. PubMed ID: 33340662
[TBL] [Abstract][Full Text] [Related]
35. Steroid sulphatase inhibitors for breast cancer therapy.
Purohit A; Woo LW; Chander SK; Newman SP; Ireson C; Ho Y; Grasso A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):423-32. PubMed ID: 14623540
[TBL] [Abstract][Full Text] [Related]
36. Coumarins: old compounds with novel promising therapeutic perspectives.
Riveiro ME; De Kimpe N; Moglioni A; Vázquez R; Monczor F; Shayo C; Davio C
Curr Med Chem; 2010; 17(13):1325-38. PubMed ID: 20166938
[TBL] [Abstract][Full Text] [Related]
37. Hybrids of Coumarin Derivatives as Potent and Multifunctional Bioactive Agents: A Review.
Fotopoulos I; Hadjipavlou-Litina D
Med Chem; 2020; 16(3):272-306. PubMed ID: 31038071
[TBL] [Abstract][Full Text] [Related]
38. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
Mamatha SV; Belagali SL; Bhat M; Kumbar VM
Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844
[TBL] [Abstract][Full Text] [Related]
39. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
Thomas MP; Potter BV
J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
[TBL] [Abstract][Full Text] [Related]
40. Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer.
Luo G; Li X; Zhang G; Wu C; Tang Z; Liu L; You Q; Xiang H
Eur J Med Chem; 2017 Nov; 140():252-273. PubMed ID: 28942113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
